ABOS   $1.6600000000000001  -2.92% Market Open

Acumen Pharmaceuticals Inc
Total Cash 260.47M
totalCashPerShare 4.335
EBITDA -76.61M
Total Debt 29.72M
quickRatio 16.957
currentRatio 17.369
Total Revenue
debtToEquity 12.185
Revenue/Share
ROA -0.20555
ROE -0.31425
grossProfits
freeCashflow -36.27M
operatingCashflow -55.62M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -36.69M
forwardPE -2.1111112
floatShares 32.42M
sharesOutstanding 60.08M
sharesShort 1.27M
sharesShortPriorMonth 1.69M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.78%
Short Ratio help_outline 8.32%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 4.06
Price To Book help_outline 0.80
earningsQuarterlyGrowth
netIncomeToCommon -64.86M
trailingEps -1.11%
forwardEps -1.53%
enterpriseToEbitda 0.48
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.36 3Q 2024
institutionsCount 112
lastUpdated Nov. 7, 2024, 5:09 a.m.